HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity.
Fakruddin
J M
JM
Laboratory for AIDS Virus Research, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA.
Laurence
J
J
D002352:Carrier Proteins / Q000187:drug effects / Q000378:metabolism*; D002460:Cell Line; D016336:Gene Products, vpr / Q000494:pharmacology*; D015497:HIV-1 / Q000737:chemistry*; D006801:Humans; D019169:Jurkat Cells; D008562:Membrane Glycoproteins / Q000187:drug effects / Q000378:metabolism*; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D011965:Receptors, Glucocorticoid / Q000378:metabolism*; D054325:vpr Gene Products, Human Immunodeficiency Virus
D002352:Carrier Proteins; D016336:Gene Products, vpr; D008562:Membrane Glycoproteins; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D011965:Receptors, Glucocorticoid; C505686:TNFRSF11A protein, human; C505688:TNFSF11 protein, human; D054325:vpr Gene Products, Human Immunodeficiency Virus